usana.com - שווי שוק בספרים USNA

The visual price representation of USANA Health Sciences (USNA) available on the page demonstrates the price action of the dietary supplement and nutrition manufacturer, whose metrics stand at 0.53. The business faces Chinese government regulation, declining agent activity, and rising raw material costs. The company has implemented automated dosing and packaging systems, while warehouses are transitioning to robotic stackers. Network marketing risks in Asia and a reduction in consumer health spending could collapse the company's revenues.

This metric is calculated as the difference between total assets and all organizational liabilities, reflecting the actual value of net assets and protecting the investor from excessive debt risks. For USANA Health Sciences (USNA), this confirms stability through the ownership of its own automated plants. Minimal outsourcing reduces dependence on external factors. The capital dynamics in the balance sheet report clearly demonstrate the preservation of the issuer's material base.